Search results
How AbbVie denied Americans access to fair competition for Humira
Quartz via Yahoo! Philippines News· 2 years agoHumira, a monoclonal antibody used to treat arthritis among other conditions, is the most lucrative...
AbbVie to pay up to $2.37 billion to settle U.S. opioid claims
Reuters via Yahoo! Philippines News· 2 years ago(Reuters) -AbbVie Inc has agreed to pay up to $2.37 billion to resolve thousands of U.S. lawsuits...
U.S. FDA approves Genmab-AbbVie's blood cancer therapy
Reuters via Yahoo! Philippines News· 1 year ago(Reuters) -The U.S. Food and Drug Administration has approved AbbVie Inc and Danish drugmaker...
AbbVie, Eli Lilly exit UK drug pricing agreement
Reuters via Yahoo! Philippines News· 1 year agoCompanies are increasingly arguing that it is no longer possible to justify the UK's "voluntary scheme" to global boardrooms and investors as repayment...
Top trending stocks after hours: Costco, Ford, Abbvie
Yahoo Finance· 2 years agoCostco (COST): Total comparable store sales rose 8.5% in September, beating Wall Street’s earnings...
Inspiring the Entertainment Industry to Include Accurate Representations of Bipolar I Disorder
Variety via Yahoo! Philippines News· 2 years agoFor more helpful resources and information on bipolar I disorder, visit LightsCameraAdvocacy.com. As...
The price of Humira's biosimilars can uncloak the secret villain of US drug pricing
Quartz via Yahoo! Philippines News· 1 year agoPharmaceutical giant AbbVie was able to delay competition to its blockbuster arthritis drug, Humira,...
Pfizer is expecting its covid windfall to end in 2023
Quartz via Yahoo! Philippines News· 1 year agoBefore 2020, vaccines would hardly bring riches to their makers. Then covid happened, and for the...
NBC Wants to Line Up Advertisers for 50th Season of ‘SNL’
Variety via Yahoo! Philippines News· 1 year agoThe 50th season of “Saturday Night Live” isn’t slated to kick off until the fall of 2024. But that...
Big Tech earnings and GDP data: What to know this week
Yahoo Finance· 2 years agoWall Street is in for a hectic last week of October as some of the market’s most heavily-weighted...